Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective Observational Cohort Study (DISCO): 48-week Results.

Suzanne M McCluskey Winnie R MuyindikeVictoria NanfukaDaniel OmodingNimusiima KomukamaIan T BarigyeLydia KansiimeJustus TumusiimeTaing N AungAshley StuckwischBethany Hedt Gauthier Mahomed-Yunus MoosaMahomed-Yunus S MoosaDeenan PillayJennifer GiandhariRichard J Lessells Ravindra Kumar Gupta Mark J Siedner

Published in: The Journal of infectious diseases (2024)

High rates of viral suppression, high tolerability, and lack of emergent drug resistance support use of TLD as the preferred first-line regimen in the region.

Keyphrases

randomized controlled trial
primary care
systematic review
healthcare
sars cov
quality improvement
clinical trial
placebo controlled
hiv infected patients